BI
CALT

BVF Inc’s Calliditas Therapeutics AB American Depositary Shares CALT Stock Holding History

BVF Inc’s Portfolio CALT Stock Details CALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-750,000
Closed -$29.2M – 62
2024
Q2 		$29.2M Hold
750,000
– – 0.82% 30
2024
Q1 		$16.2M Hold
750,000
– – 0.45% 35
2023
Q4 		$19.3M Hold
750,000
– – 0.48% 39
2023
Q3 		$13.7M Hold
750,000
– – 0.37% 43
2023
Q2 		$11.8M Hold
750,000
– – 0.33% 44
2023
Q1 		$18M Hold
750,000
– – 0.66% 39
2022
Q4 		$13.1M Hold
750,000
– – 0.55% 45
2022
Q3 		$11.3M Hold
750,000
– – 0.47% 51
2022
Q2 		$13.5M Hold
750,000
– – 0.65% 42
2022
Q1 		$13.9M Hold
750,000
– – 0.56% 50
2021
Q4 		$18.6M Hold
750,000
– – 0.67% 42
2021
Q3 		$16.2M Hold
750,000
– – 0.63% 45
2021
Q2 		$22.1M Hold
750,000
– – 0.83% 32
2021
Q1 		$20.7M Hold
750,000
– – 0.78% 32
2020
Q4 		$25.5M Hold
750,000
– – 1% 28
2020
Q3 		$18M Hold
750,000
– – 0.98% 34
2020
Q2 		$17.5M Buy
+750,000
New +$14.9M 1.08% 29

Other funds holding CALT

CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return
AP
Advisors Preferred Rockville, Maryland $679M AUM 22.19% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
MTIC
Missouri Trust & Investment Company Springfield, Missouri $341M AUM 17.31% 1-Year Est. Return

BVF Inc's CALT Position: Q3 2024 in Review

BVF Inc sold out of Calliditas Therapeutics AB American Depositary Shares (CALT) in Q3 2024, closing a stake of 750,000 shares — an estimated $29.2M sold.

BVF Inc first reported a position in CALT in Q2 2020 and held it in 17 quarters. The position peaked at $29.2M in Q2 2024. 5 funds tracked by Wall St. Rank hold CALT as of Q3 2024.

  • BVF Inc reported no remaining Calliditas Therapeutics AB American Depositary Shares position as of Q3 2024 after selling out during the quarter.
  • BVF Inc sold 750,000 Calliditas Therapeutics AB American Depositary Shares shares in Q3 2024, an estimated $29.2M.
  • BVF Inc first reported a position in Calliditas Therapeutics AB American Depositary Shares in Q2 2020 and held it in 17 quarters.
  • BVF Inc's Calliditas Therapeutics AB American Depositary Shares position peaked at $29.2M in Q2 2024.
  • 5 funds tracked by Wall St. Rank held Calliditas Therapeutics AB American Depositary Shares as of Q3 2024.

Based on BVF Inc's 13F filing for Q3 2024, filed 14 Nov 2024.